Clinical Trial

RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)

Study acronym: RHAPSODY
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-12 -> 2027-12 2026-07-01
minor Completion pushed: 2026-12 -> 2027-12 2026-07-01
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-05-05
Trial Details
NCT Number NCT03053141
Lead Sponsor Boston Scientific Corporation
Conditions Cardiac Arrythmias
Enrollment 100 participants
Start Date 2016-05
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-31